| 1 |
34845147 | Pharmacotherapy of cerebellar and vestibular disorders. | 2022 Feb 1 |
2 |
| 2 |
34484942 | Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial. | 2021 Aug |
4 |
| 3 |
32899500 | Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2. | 2020 Sep 5 |
1 |
| 4 |
30873657 | AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). | 2019 May |
1 |
| 5 |
30881862 | A novel mutation in CACNA1A gene in a Saudi female with episodic ataxia type 2 with no response to acetazolamide or 4-aminopyridine. | 2019 Feb |
1 |
| 6 |
27829685 | Late-onset episodic ataxia associated with SLC1A3 mutation. | 2017 Mar |
1 |
| 7 |
28643957 | Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation. | 2017 Jul |
1 |
| 8 |
25855180 | Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse. | 2015 Apr 8 |
1 |
| 9 |
24768804 | RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2. | 2014 Aug |
1 |
| 10 |
24665320 | Downward vertical gaze palsy as a prominent manifestation of episodic ataxia type 2: a case report. | 2013 Fall |
1 |
| 11 |
21827920 | Episodic ataxias 1 and 2. | 2012 |
1 |
| 12 |
20663518 | Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q. | 2010 Sep 15 |
2 |
| 13 |
18602318 | Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia and interictal chronic diarrhea due to a novel CACNA1A mutation. | 2009 Mar |
1 |
| 14 |
17292920 | Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. | 2007 Mar 15 |
2 |
| 15 |
17395137 | Episodic ataxia type 2. | 2007 Apr |
2 |
| 16 |
16583725 | CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. | 2006 Feb |
5 |
| 17 |
14991363 | Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2). | 2004 Feb |
2 |
| 18 |
15136697 | Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. | 2004 May 11 |
2 |
| 19 |
15293273 | Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. | 2004 Aug |
1 |
| 20 |
12603362 | Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. | 2003 Mar |
1 |
| 21 |
11985388 | Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. | 2002 Feb |
1 |
| 22 |
11992880 | Ocular motility in genetically defined autosomal dominant cerebellar ataxia. | 2002 May |
3 |
| 23 |
11176968 | Missense CACNA1A mutation causing episodic ataxia type 2. | 2001 Feb |
1 |
| 24 |
11442442 | Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry. | 2001 Jul |
5 |
| 25 |
11748369 | Spinocerebellar ataxia type 6 and episodic ataxia type 2 in a Korean family. | 2001 Dec |
1 |
| 26 |
10371528 | High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. | 1999 Jun 10 |
1 |
| 27 |
10408534 | A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. | 1999 Jul 13 |
1 |
| 28 |
10586621 | [A clinical trial of acetazolamide for SCA6]. | 1999 Aug |
4 |
| 29 |
9600739 | De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia. | 1998 May 26 |
2 |
| 30 |
9771787 | Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. | 1998 Oct |
1 |
| 31 |
7757080 | Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. | 1995 Feb |
1 |